Learn what’s behind dog tummy troubles and how to shop smarter for their food.
SAN FRANCISCO, CA / ACCESSWIRE / February 16, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal Health tradename for the veterinary market, today announced that it has submitted a ...
, February 10, 2022 (Newswire.com) - Canalevia ™ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrhea Jaguar Health, Inc. (NASDAQ:JAGX), under its ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...
Jaguar’s recently completed pivotal effectiveness study of crofelemer for the treatment of CID in dogs demonstrates positive, statistically significant results SAN FRANCISCO, CA / ACCESS Newswire / ...
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license ... · ACCESS Newswire · Jaguar Health, Inc. "I'm pleased to report that ...
, May 3, 2022 (Newswire.com) - Canalevia® Would Be the First and Only Treatment for EID in Dogs To Receive Any Type of Approval From FDA Jaguar Health, Inc. (NASDAQ:JAGX), under its Jaguar Animal ...
SAN FRANCISCO, CA / ACCESS Newswire / August 21, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”), under its Jaguar Animal Health tradename for the veterinary market, today announced it is ...